GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
B

Biontech BNTX · USD

Health Care · US listing · 🇺🇸 United States

Compare

87.51

0.00%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in EUR, from our data supplier.

FY2025

Revenue

€3.18bn

FY2017FY2025

Net income

−€1.26bn

FY2017FY2025

Free cash flow

€311.4m

FY2017FY2025

Shareholders' equity

€22.18bn

FY2017FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue€3.18bn€3.18bn€4.41bn€19.98bn€21.90bn€556.6m€125.3m€147.2m€71.1m
Gross profit€2.47bn€2.55bn€3.72bn€16.52bn€18.54bn€488.2m€105.3m€131.4m€60.3m
Research and development€2.33bn€2.60bn€2.06bn€1.77bn€1.10bn€744.4m€261.4m€165.1m€98.7m
Operating income−€720.0m−€1.52bn€796.8m€14.59bn€17.64bn−€95.1m−€209.5m−€62.2m−€70.7m
Net income−€1.26bn−€767.8m€1.07bn€10.89bn€11.88bn€17.5m−€206.7m−€55.4m−€98.9m
Diluted earnings per share-5.14-3.204.4644.2545.730.07-0.90-0.24-0.44

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assets€25.37bn€26.00bn€26.55bn€26.87bn€18.27bn€2.68bn€920.6m€753.6m€432.5m
Cash and short-term investments€17.12bn€19.37bn€19.10bn€16.23bn€2.39bn€1.56bn€601.1m€475.3m€198.9m
Total liabilities€3.19bn€3.60bn€3.19bn€3.72bn€4.54bn€1.09bn€351.0m€445.5m€488.1m
Debt€308.6m€254.2m€219.1m€212.0m€302.0m€237.0m€72.0m€14.0m€2.0m
Shareholders' equity€22.18bn€22.40bn€23.37bn€23.15bn€13.73bn€1.58bn€569.5m€307.2m−€56.9m
Shares outstanding245m240m241m246m260m245m230m227m227m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations€505.5m€239.7m€6.20bn€15.67bn€1.03bn−€15.6m−€229.1m−€67.1m−€60.7m
Capital spending−€194.1m−€522.0m−€814.2m−€419.3m−€177.7m−€98.6m−€82.1m−€78.3m−€66.6m
Free cash flow€311.4m−€282.3m€5.38bn€15.25bn€849.1m−€114.1m−€311.1m−€145.5m−€127.3m
Dividends paid———−€558.9m—————

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue€123.9m€138.5m€1.04bn€1.75bn€301.0m€211.0m€1.37bn€1.44bn
Gross profit−€188.3m−€87.5m€656.4m€1.58bn€212.8m€114.3m€1.09bn€1.23bn
Operating income−€868.4m−€775.5m−€266.2m€29.0m−€578.3m−€616.4m€239.6m€12.1m
Net income−€963.0m−€624.0m−€348.7m−€33.1m−€446.2m−€479.9m€299.5m€228.6m
Diluted earnings per share-3.80-2.46-1.42-0.14-1.82-1.961.250.95
Cash from operations€12.0m−€493.0m€345.0m€986.0m€152.0m−€948.0m−€578.0m−€793.0m
Capital spending−€64.0m−€66.0m−€70.0m−€50.0m−€655.0m−€750.0m−€115.0m−€104.0m
Free cash flow−€52.0m−€559.0m€275.0m€936.0m−€503.0m−€1.70bn−€693.0m−€897.0m
Total assets€23.47bn€24.35bn€25.37bn€24.63bn€24.97bn€24.45bn€26.00bn€25.85bn
Cash and short-term investments€11.24bn€16.91bn€17.12bn€16.77bn€16.20bn€16.28bn€19.37bn€19.28bn
Debt€364.8m€349.5m€308.6m€283.2m€311.1m€338.2m€293.4m€281.3m
Shareholders' equity€20.49bn€21.60bn€22.18bn€21.32bn€21.36bn€21.84bn€22.40bn€22.06bn

Financial ratios

Data as of 25 Sept 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin77.6%80.3%84.3%82.7%84.7%87.7%
Operating margin-22.6%-47.8%18.1%73.0%80.5%-17.1%
Net margin-39.6%-24.2%24.4%54.5%54.2%3.2%
Return on equity-5.7%-3.4%4.6%47.0%86.5%1.1%
Return on assets-5.0%-3.0%4.0%40.5%65.0%0.7%
Free cash flow yield2.5%2.8%25.4%57.1%4.0%0.3%
Revenue growth0.2%-28.0%-77.9%-8.8%3834.6%344.1%
Earnings growth64.0%-171.5%-90.1%-8.3%67613.8%-108.5%
Current ratio7.54x7.45x9.43x7.43x4.33x2.75x
Debt to equity0.01x0.01x0.01x0.01x0.03x0.18x
Equity ratio87.4%86.2%88.0%86.2%75.1%59.2%
Interest coverage-45.74x-99.86x88.96x799.08x2715.05x-44.21x
R&D as a share of sales73.3%81.9%46.7%8.9%5.0%133.7%
Buybacks as a share of market value-2.0%0.3%2.1%5.3%-6.2%-6.3%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-45.9%41.9%—
Operating income—49.9%—

Average margins

Over each period

1 year3 years5 years10 years
Gross margin79.0%82.2%83.2%—

Valuation history

At each fiscal year end

FY2025FY2024
Price to earnings-16.2-31.2
Price to sales6.57.6

Market value over time

31 Oct 2019 to 24 Sept 2026, in EUR

€3.62bn€25.15bn

Share price return

Finished calendar years

20252024
Return-18%39%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years. Last went ex-dividend on 2 Jun 2022.

FY2022
Paid in the year2.132

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.